close
close

Relief Therapeutics Announces Presentation of PKU GOLIKE Study Results at SSIEM 2024

Relief Therapeutics Announces Presentation of PKU GOLIKE Study Results at SSIEM 2024

GENEVA, SWITZERLAND / ACCESSWIRE / September 2, 2024 / RELIEF THERAPEUTICS Holding SA (SIX:RLF) (OTCQB:RLFTF) (OTCQB:RLFTY) (Relief, or the Company), a biopharmaceutical company focused on providing …